Objective:: Mechanisms involved in developing intervertebral disc degeneration (IDD) are poorly understood, thus making developing effective therapies difficult. This study aimed to suggest a possible molecular mechanism, based on transcriptome sequencing-identified transforming growth factor (TGF-β), underlying the effects on bone homeostasis in IDD.
Methods:: A mouse model for IDD was established. Transcriptome sequencing of nucleus pulposus tissue from mice (n = 3) identified differentially expressed mRNAs and key genes impacting bone homeostasis. A protein–protein interaction network pinpointed core genes. GO and KEGG analysis revealed gene functions. Expression levels of TGF-β1, tartrate-resistant acid phosphatase (TRAP), and cathepsin K (CTSK) were measured. Micro-CT evaluated vertebral structures and vascular imaging. Western Blot measured expression levels of Vegf, Opn, MMP3, and MMP13. Safranin O-Fast Green and TRAP staining were performed on intervertebral discs and endplates.
Results:: Transcriptomic analysis found 1790 differentially expressed mRNAs in IDD mice. Twenty-eight genes related to bone homeostasis in IDD were identified. TGF-β1 was confirmed as the core gene. GO and KEGG showed TGF-β1 regulates osteoclast markers like CTSK and TRAP through pathways including NF-κB and MAPK. Experimental validation revealed lower TGF-β1 expression in IDD mice than controls, and increased TRAP and CTSK expression. Micro-CT showed decreased bone mass and intervertebral disc space in IDD mice. Vascular imaging showed increased vascular volume in IDD cartilaginous endplates. Western blot displayed increased VEGF and OPN levels, but decreased MMP3 and MMP13 in IDD mice. Safranin O-fast green staining revealed severe IDD degeneration. However, TGF-β1 injection improved bone parameters in IDD mice. In vitro experiments confirmed TGF-β1 inhibits bone marrow macrophages differentiation into osteoclasts.
Conclusion:: From our data, we conclude that TGF-β1 repressed osteoclast differentiation and aberrant bone-associated angiogenesis in cartilage endplates (EPs) to alleviate IDD, which may be instrumental for the therapeutic targeting of IDD.
| [1] |
Kirnaz S, Capadona C, Wong T, Goldberg JL, Medary B, Sommer F, et al. Fundamentals of intervertebral disc degeneration. World Neurosurg. 2022;157:264–273.
|
| [2] |
Vergroesen PP, Kingma I, Emanuel KS, et al. Mechanics and biology in intervertebral disc degeneration: a vicious circle. Osteoarthr Cartil. 2015;23(7):1057–1070.
|
| [3] |
Kos N, Gradisnik L, Velnar T. A brief review of the degenerative intervertebral disc disease. Med Arch. 2019;73(6):421–424.
|
| [4] |
Liu Q, Wang X, Hua Y, Kong G, Wu X, Huang Z, et al. Estrogen deficiency exacerbates intervertebral disc degeneration induced by spinal instability in rats. Spine. 2019;44(9):E510–E519.
|
| [5] |
Xia W, Zhang LL, Mo J, Zhang W, Li HT, Luo ZP, et al. Effect of static compression loads on intervertebral disc: an in vivo bent rat tail model. Orthop Surg. 2018;10(2):134–143.
|
| [6] |
Ding F, Shao ZW, Xiong LM. Cell death in intervertebral disc degeneration. Apoptosis. 2013;18(7):777–785.
|
| [7] |
Sessler T, Healy S, Samali A, Szegezdi E. Structural determinants of DISC function: new insights into death receptor-mediated apoptosis signalling. Pharmacol Ther. 2013;140(2):186–199.
|
| [8] |
Walsh AJ, Bradford DS, Lotz JC. In vivo growth factor treatment of degenerated intervertebral discs. Spine. 2004;29(2):156–163.
|
| [9] |
Massague J. TGF-beta signal transduction. Annu Rev Biochem. 1998;67:753–791.
|
| [10] |
Janssens K, ten Dijke P, Janssens S, Van Hul W. Transforming growth factor-beta1 to the bone. Endocr Rev. 2005;26(6):743–774.
|
| [11] |
Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A. 1993;90(2):770–774.
|
| [12] |
Masuda K, An HS. Growth factors and the intervertebral disc. Spine J. 2004;4(6 Suppl):330S–340S.
|
| [13] |
Nishida K, Kang JD, Gilbertson LG, Moon SH, Suh JK, Vogt MT, et al. Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine. 1999;24(23):2419–2425.
|
| [14] |
Wang SL, Yu YL, Tang CL, Lv FZ. Effects of TGF-beta1 and IL-1beta on expression of ADAMTS enzymes and TIMP-3 in human intervertebral disc degeneration. Exp Ther Med. 2013;6(6):1522–1526.
|
| [15] |
Tsuji T, Chiba K, Imabayashi H, Fujita Y, Hosogane N, Okada Y, et al. Age-related changes in expression of tissue inhibitor of metalloproteinases-3 associated with transition from the notochordal nucleus pulposus to the fibrocartilaginous nucleus pulposus in rabbit intervertebral disc. Spine. 2007;32(8):849–856.
|
| [16] |
Pattison ST, Melrose J, Ghosh P, Taylor TK. Regulation of gelatinase-a (MMP-2) production by ovine intervertebral disc nucleus pulposus cells grown in alginate bead culture by transforming growth factor-beta(1) and insulin like growth factor-I. Cell Biol Int. 2001;25(7):679–689.
|
| [17] |
Yang H, Cao C, Wu C, Yuan C, Gu Q, Shi Q, et al. TGF-betal suppresses inflammation in cell therapy for intervertebral disc degeneration. Sci Rep. 2015;5:13254.
|
| [18] |
Li H, Li W, Liang B, Wei J, Yin D, Fan Q. Role of AP-2alpha/TGF-beta1/Smad3 axis in rats with intervertebral disc degeneration. Life Sci. 2020;263:118567.
|
| [19] |
Yang H, Yuan C, Wu C, Qian J, Shi Q, Li X, et al. The role of TGF-beta1/Smad2/3 pathway in platelet-rich plasma in retarding intervertebral disc degeneration. J Cell Mol Med. 2016;20(8):1542–1549.
|
| [20] |
Chen WH, Lo WC, Lee JJ, Su CH, Lin CT, Liu HY, et al. Tissue-engineered intervertebral disc and chondrogenesis using human nucleus pulposus regulated through TGF-beta1 in platelet-rich plasma. J Cell Physiol. 2006;209(3):744–754.
|
| [21] |
Gruber HE, Fisher EC, Desai B, Stasky AA, Hoelscher G, Hanley EN. Human intervertebral disc cells from the annulus: three-dimensional culture in agarose or alginate and responsiveness to TGF-beta1. Exp Cell Res. 1997;235(1):13–21.
|
| [22] |
Cai F, Zhu L, Wang F, Shi R, Xie XH, Hong X, et al. The paracrine effect of degenerated disc cells on healthy human nucleus pulposus cells is mediated by MAPK and NF-kappaB pathways and can Be reduced by TGF-beta1. DNA Cell Biol. 2017;36(2):143–158.
|
| [23] |
Ao X, Wang L, Shao Y, Chen X, Zhang J, Chu J, et al. Development and characterization of a novel bipedal standing mouse model of intervertebral disc and facet joint degeneration. Clin Orthop Relat Res. 2019;477(6):1492–1504.
|
| [24] |
Pistell PJ, Ingram DK. Development of a water-escape motivated version of the stone T-maze for mice. Neuroscience. 2010;166(1):61–72.
|
| [25] |
Ndaw VS, Abebayehu D, Spence AJ, Paez PA, Kolawole EM, Taruselli MT, et al. TGF-beta1 suppresses IL-33-induced mast cell function. J Immunol. 2017;199(3):866–873.
|
| [26] |
Lai A, Moon A, Purmessur D, Skovrlj B, Laudier DM, Winkelstein BA, et al. Annular puncture with tumor necrosis factor-alpha injection enhances painful behavior with disc degeneration in vivo. Spine J. 2016;16(3):420–431.
|
| [27] |
Kim J, Cho M, Lim J, Choi H, Hong S. Pathogenic mechanism of a highly virulent infectious hematopoietic necrosis virus in head kidney of rainbow trout (Oncorhynchusmykiss) analyzed by RNA-seq transcriptome profiling. Viruses. 2022;14(5):859.
|
| [28] |
Liu F, Li Y, Li M, Wang J, Zhang Y, du Y, et al. Study on mechanism of iridoid glycosides derivatives from fructus Gardeniae in Jiangxi Province by network pharmacology. Evid Based Complement Alternat Med. 2020;2020:4062813.
|
| [29] |
Zhao H, Zhang J, Shao H, Liu J, Jin M, Chen J, et al. Transforming growth factor beta1/Smad4 signaling affects osteoclast differentiation via regulation of miR-155 expression. Mol Cells. 2017;40(3):211–221.
|
| [30] |
Xiao ZF, He JB, Su GY, Chen MH, Hou Y, Chen SD, et al. Osteoporosis of the vertebra and osteochondral remodeling of the endplate causes intervertebral disc degeneration in ovariectomized mice. Arthritis Res Ther. 2018;20(1):207.
|
| [31] |
Bian Q, Jain A, Xu X, Kebaish K, Crane JL, Zhang Z, et al. Excessive activation of TGFbeta by spinal instability causes vertebral endplate sclerosis. Sci Rep. 2016;6:27093.
|
| [32] |
Tang Y, Hu M, Xu Y, Chen F, Chen S, Chen M, et al. Megakaryocytes promote bone formation through coupling osteogenesis with angiogenesis by secreting TGF-beta1. Theranostics. 2020;10(5):2229–2242.
|
| [33] |
Duvall CL, Taylor WR, Weiss D, Guldberg RE. Quantitative microcomputed tomography analysis of collateral vessel development after ischemic injury. Am J Physiol Heart Circ Physiol. 2004;287(1):H302–H310.
|
| [34] |
Wang Y, Wan C, Deng L, Liu X, Cao X, Gilbert SR, et al. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest. 2007;117(6):1616–1626.
|
| [35] |
Liang N, Li Y, Chung HY. Two natural eudesmane-type sesquiterpenes from Laggera alata inhibit angiogenesis and suppress breast cancer cell migration through VEGF- and angiopoietin 2-mediated signaling pathways. Int J Oncol. 2017;51(1):213–222.
|
| [36] |
Zou S, Wang C, Cui Z, Guo P, Meng Q, Shi X, et al. Beta-Elemene induces apoptosis of human rheumatoid arthritis fibroblast-like synoviocytes via reactive oxygen species-dependent activation of p38 mitogen-activated protein kinase. Pharmacol Rep. 2016;68(1):7–11.
|
| [37] |
Ban Z, He J, Tang Z, Zhang L, Xu Z. LRG-1 enhances the migration of thyroid carcinoma cells through promotion of the epithelial-mesenchymal transition by activating MAPK/p38 signaling. Oncol Rep. 2019;41(6):3270–3280.
|
| [38] |
Xia C, Zeng Z, Fang B, Tao M, Gu C, Zheng L, et al. Mesenchymal stem cell-derived exosomes ameliorate intervertebral disc degeneration via anti-oxidant and anti-inflammatory effects. Free Radic Biol Med. 2019;143:1–15.
|
| [39] |
Born GV. Polypharmacologic interactions in the management of thrombosis. Semin Thromb Hemost. 1989;15(2):140–143.
|
| [40] |
Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, et al. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. 2016;54:1.30.1–1.30.33.
|
| [41] |
Nerlich AG, Bachmeier BE, Boos N. Expression of fibronectin and TGF-beta1 mRNA and protein suggest altered regulation of extracellular matrix in degenerated disc tissue. Eur Spine J. 2005;14(1):17–26.
|
| [42] |
Crane JL, Cao X. Bone marrow mesenchymal stem cells and TGF-beta signaling in bone remodeling. J Clin Invest. 2014;124(2):466–472.
|
| [43] |
Chen Q, Yao Y, Chen K, Chen X, Li B, Li R, et al. Aberrant activation of TGF-beta1 induces high bone turnover via rho GTPases-mediated cytoskeletal remodeling in Camurati-Engelmann disease. Front Endocrinol. 2022;13:913979.
|
| [44] |
Chen S, Liu S, Ma K, Zhao L, Lin H, Shao Z. TGF-beta signaling in intervertebral disc health and disease. Osteoarthr Cartil. 2019;27(8):1109–1117.
|
| [45] |
Dallas SL, Park-Snyder S, Miyazono K, Twardzik D, Mundy GR, Bonewald LF. Characterization and autoregulation of latent transforming growth factor beta (TGF beta) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGF beta-binding protein. J Biol Chem. 1994;269(9):6815–6821.
|
| [46] |
Tang Y, Wu X, Lei W, Pang L, Wan C, Shi Z, et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med. 2009;15(7):757–765.
|
| [47] |
Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126(6):1121–1133.
|
| [48] |
Good SR, Thieu VT, Mathur AN, Yu Q, Stritesky GL, Yeh N, et al. Temporal induction pattern of STAT4 target genes defines potential for Th1 lineage-specific programming. J Immunol. 2009;183(6):3839–3847.
|
| [49] |
Von Forell GA, Nelson TG, Samartzis D, Bowden AE. Changes in vertebral strain energy correlate with increased presence of Schmorl's nodes in multi-level lumbar disk degeneration. J Biomech Eng. 2014;136(6):061002.
|
| [50] |
Ramasamy SK, Kusumbe AP, Wang L, Adams RH. Endothelial notch activity promotes angiogenesis and osteogenesis in bone. Nature. 2014;507(7492):376–380.
|
| [51] |
Kusumbe AP, Ramasamy SK, Adams RH. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature. 2014;507(7492):323–328.
|
| [52] |
Laffosse JM, Accadbled F, Molinier F, Bonnevialle N, de Gauzy JS, Swider P. Correlations between effective permeability and marrow contact channels surface of vertebral endplates. J Orthop Res. 2010;28(9):1229–1234.
|
| [53] |
Zhang J, Li Z, Chen F, Liu H, Wang H, Li X, et al. TGF-beta1 suppresses CCL3/4 expression through the ERK signaling pathway and inhibits intervertebral disc degeneration and inflammation-related pain in a rat model. Exp Mol Med. 2017;49(9):e379.
|
| [54] |
Yang H, Wu J, Liu J, Ebraheim M, Castillo S, Liu X, et al. Transplanted mesenchymal stem cells with pure fibrinous gelatin-transforming growth factor-beta1 decrease rabbit intervertebral disc degeneration. Spine J. 2010;10(9):802–810.
|
RIGHTS & PERMISSIONS
2023 The Authors. Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.
PDF
